Literature DB >> 26106125

Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors.

René G Feichtinger1, Serge Weis1, Johannes A Mayr1, Franz A Zimmermann1, Barbara Bogner1, Wolfgang Sperl1, Barbara Kofler1.   

Abstract

BACKGROUND: Changes in the mode of aerobic energy production are observed in many solid tumors, though the kinds of changes differ among tumor types. We investigated mitochondrial energy metabolism in meningiomas and peripheral nerve sheath tumors, taking into consideration the histologic heterogeneity of these tumors.
METHODS: Oxidative phosphorylation (OXPHOS) complexes and porin (a marker for mitochondrial mass) were analyzed by immunohistochemical staining of meningiomas (n = 76) and peripheral nerve sheath tumors (schwannomas: n = 10; neurofibromas: n = 4). The enzymatic activities of OXPHOS complexes and citrate synthase were determined by spectrophotometric measurement. Western blot analysis of OXPHOS complexes, porin, and mitochondrial transcription factor A was performed. Furthermore, mitochondrial DNA copy number was determined.
RESULTS: The tumors differed with regard to mitochondrial energy metabolism. Low levels of a subset of OXPHOS complexes were frequently observed in World Health Organization grade I meningiomas (percent of cases with a reduction; complex I: 63%; complex II: 67%; complex IV: 56%) and schwannomas (complex III: 40%, complex IV: 100%), whereas in neurofibromas a general reduction of all complexes was observed. In contrast, expression of complexes III and V was similar to that in normal brain tissue in the majority of tumors. Mitochondrial mass was comparable or higher in all tumors compared with normal brain tissue, whereas mitochondrial DNA copy number was reduced.
CONCLUSIONS: The reduction of OXPHOS complexes in meningiomas and peripheral nerve sheath tumors has potential therapeutic implications, since respiratory chain-deficient tumor cells might be selectively starved by inhibitors of glycolysis or by ketogenic diet.
© The Author(s) 2015. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  meningioma; neurofibroma; oxidative phosphorylation; respiratory chain deficiency; schwannoma

Mesh:

Substances:

Year:  2015        PMID: 26106125      PMCID: PMC4724172          DOI: 10.1093/neuonc/nov105

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  50 in total

1.  Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.

Authors:  Daniel Monleón; José Manuel Morales; Ana Gonzalez-Segura; José Manuel Gonzalez-Darder; Rosario Gil-Benso; Miguel Cerdá-Nicolás; Concepción López-Ginés
Journal:  Cancer Res       Date:  2010-09-21       Impact factor: 12.701

Review 2.  Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.

Authors:  Anthony J Gill
Journal:  Pathology       Date:  2012-06       Impact factor: 5.306

Review 3.  Regulation of metabolism by hypoxia-inducible factor 1.

Authors:  G L Semenza
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-07-22

Review 4.  Pathological classification and molecular genetics of meningiomas.

Authors:  Christian Mawrin; Arie Perry
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

5.  Telomere dysfunction induces metabolic and mitochondrial compromise.

Authors:  Ergün Sahin; Simona Colla; Marc Liesa; Javid Moslehi; Florian L Müller; Mira Guo; Marcus Cooper; Darrell Kotton; Attila J Fabian; Carl Walkey; Richard S Maser; Giovanni Tonon; Friedrich Foerster; Robert Xiong; Y Alan Wang; Sachet A Shukla; Mariela Jaskelioff; Eric S Martin; Timothy P Heffernan; Alexei Protopopov; Elena Ivanova; John E Mahoney; Maria Kost-Alimova; Samuel R Perry; Roderick Bronson; Ronglih Liao; Richard Mulligan; Orian S Shirihai; Lynda Chin; Ronald A DePinho
Journal:  Nature       Date:  2011-02-09       Impact factor: 49.962

6.  Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.

Authors:  K Ueki; C Wen-Bin; Y Narita; A Asai; T Kirino
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

Review 7.  The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.

Authors:  Winward Choy; Won Kim; Daniel Nagasawa; Stephanie Stramotas; Andrew Yew; Quinton Gopen; Andrew T Parsa; Isaac Yang
Journal:  Neurosurg Focus       Date:  2011-05       Impact factor: 4.047

Review 8.  Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors.

Authors:  Franz A Zimmermann; Johannes A Mayr; Rene Feichtinger; Daniel Neureiter; Roman Lechner; Christian Koegler; Manfred Ratschek; Husic Rusmir; Karine Sargsyan; Wolfgang Sperl; Barbara Kofler
Journal:  Front Biosci (Elite Ed)       Date:  2011-01-01

9.  Loss of mitochondria in ganglioneuromas.

Authors:  Rene' G Feichtinger; Daniel Neureiter; Johannes A Mayr; Franz A Zimmermann; Frank Berthold; Neil Jones; Wolfgang Sperl; Barbara Kofler
Journal:  Front Biosci (Elite Ed)       Date:  2011-01-01

10.  Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model.

Authors:  Raphael Johannes Morscher; Sepideh Aminzadeh-Gohari; René Gunther Feichtinger; Johannes Adalbert Mayr; Roland Lang; Daniel Neureiter; Wolfgang Sperl; Barbara Kofler
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

View more
  5 in total

1.  The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome.

Authors:  Silvia Vidali; Sepideh Aminzadeh-Gohari; René Günther Feichtinger; Renaud Vatrinet; Andreas Koller; Felix Locker; Tricia Rutherford; Maura O'Donnell; Andrea Stöger-Kleiber; Bridget Lambert; Thomas Klaus Felder; Wolfgang Sperl; Barbara Kofler
Journal:  Oncotarget       Date:  2017-07-17

2.  Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis.

Authors:  René G Feichtinger; Daniel Neureiter; Tom Skaria; Silja Wessler; Timothy L Cover; Johannes A Mayr; Franz A Zimmermann; Gernot Posselt; Wolfgang Sperl; Barbara Kofler
Journal:  Oxid Med Cell Longev       Date:  2017-06-28       Impact factor: 6.543

3.  Reduced Levels of ATP Synthase Subunit ATP5F1A Correlate with Earlier-Onset Prostate Cancer.

Authors:  René G Feichtinger; Georg Schäfer; Christof Seifarth; Johannes A Mayr; Barbara Kofler; Helmut Klocker
Journal:  Oxid Med Cell Longev       Date:  2018-11-14       Impact factor: 6.543

4.  Peroxynitrite supports a metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival.

Authors:  Jeanine C Pestoni; Stephani Klingeman Plati; Oliver D Valdivia Camacho; Marisa A Fuse; Maria Onatunde; Nicklaus A Sparrow; Matthias A Karajannis; Cristina Fernández-Valle; Maria Clara Franco
Journal:  J Biol Chem       Date:  2019-06-06       Impact factor: 5.157

5.  Case Report and Review of the Literature: A New and a Recurrent Variant in the VARS2 Gene Are Associated With Isolated Lethal Hypertrophic Cardiomyopathy, Hyperlactatemia, and Pulmonary Hypertension in Early Infancy.

Authors:  Katarína Kušíková; René Günther Feichtinger; Bernhard Csillag; Ognian Kostadinov Kalev; Serge Weis; Hans-Christoph Duba; Johannes Adalbert Mayr; Denisa Weis
Journal:  Front Pediatr       Date:  2021-04-16       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.